TriReme signs master distribution agreement in China

Source：TriReme Medical, Inc. Release Date：2013-03-27 197

Medical Equipment

Percutaneous devices specialist Trireme says master distributor, Weigao, is one of largest medical device players in the Middle Kingdom

PLEASANTON, Calif. and SINGAPORE-- Privately held medical device company TriReme Medical, Inc. and its affiliates announced a comprehensive agreement with Weihai Weigao Medical Devices, Ltd for the distribution of its products in China. This agreement complements TriReme's strategy of focusing on Asia, the fastest growing market in interventional cardiology.

Based in Singapore and Pleasanton, California, TriReme develops, manufactures and markets next generation percutaneous devices for the treatment of complex coronary and peripheral arterial disease.

Weigao will act as TriReme's master distributor by selling TriReme products directly to hospitals as well as connecting TriReme products into its vast nationwide distribution network.

"Due to many factors including increased affordability, aging population and an increase in the number of state-of-the-art medical facilities, China has become the world's second largest market in terms of the volume of interventional coronary vascular procedures," said Eitan Konstantino Ph.D, CEO and president of TriReme. "For similar reasons, we expect that the number of peripheral vascular procedures will rise dramatically in the coming years to the point where China becomes the world's largest market in terms of total vascular interventions."

Based in Weihai, and publicly traded on the Hong Kong Stock exchange (Stock Code: 1066), Weigao manufactures and sells over 100 types of products, including disposable medical consumables, orthopedic materials and tools, medical needles, blood purification consumables, and interventional cardiology devices. It maintains a vast distribution network of 24 regional sales offices, 30 customer service centers, 100 municipal representatives, and 1200 sales representatives. It sells to over 2700 hospitals, 400 blood stations, and over 1500 distribution/trading partners across China.

"Weigao remains committed to partnering with healthcare providers across China to provide access to best-in-class technology across a wide range of product categories," explained Mr SunFeng Wei, general manager of Weigao Medical Devices. "We view TriReme as a top brand and this partnership allows us to bring the highest quality devices to our growing customer base of physicians performing interventional vascular procedures."Nike Air Penny 2